adenine has been researched along with Cancer of the Retina in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the inhibition of retinoblastoma cell viability by two commonly used autophagy inhibitors, chloroquine (CQ) and 3-methyladenine (3-MA), alone or in combination with the conventional chemotherapeutic drug vincristine (VCR), and to investigate whether the mechanisms of these drugs are related to inhibition of autophagy." | 7.81 | Low concentrations of chloroquine and 3-methyladenine suppress the viability of retinoblastoma cells synergistically with vincristine independent of autophagy inhibition. ( Chen, X; Chen, YH; Jiang, PF; Li, LJ; Li, W; Shen, HQ; Zheng, XY, 2015) |
| "To study the inhibition of retinoblastoma cell viability by two commonly used autophagy inhibitors, chloroquine (CQ) and 3-methyladenine (3-MA), alone or in combination with the conventional chemotherapeutic drug vincristine (VCR), and to investigate whether the mechanisms of these drugs are related to inhibition of autophagy." | 3.81 | Low concentrations of chloroquine and 3-methyladenine suppress the viability of retinoblastoma cells synergistically with vincristine independent of autophagy inhibition. ( Chen, X; Chen, YH; Jiang, PF; Li, LJ; Li, W; Shen, HQ; Zheng, XY, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Mathai, M | 1 |
| Fein, JG | 1 |
| Soussain, C | 1 |
| Choquet, S | 1 |
| Blonski, M | 1 |
| Leclercq, D | 1 |
| Houillier, C | 1 |
| Rezai, K | 1 |
| Bijou, F | 1 |
| Houot, R | 1 |
| Boyle, E | 1 |
| Gressin, R | 1 |
| Nicolas-Virelizier, E | 1 |
| Barrie, M | 1 |
| Moluçon-Chabrot, C | 1 |
| Lelez, ML | 1 |
| Clavert, A | 1 |
| Coisy, S | 1 |
| Leruez, S | 1 |
| Touitou, V | 1 |
| Cassoux, N | 1 |
| Daniau, M | 1 |
| Ertault de la Bretonnière, M | 1 |
| El Yamani, A | 1 |
| Ghesquières, H | 1 |
| Hoang-Xuan, K | 1 |
| Zheng, XY | 1 |
| Li, LJ | 1 |
| Li, W | 1 |
| Jiang, PF | 1 |
| Shen, HQ | 1 |
| Chen, YH | 1 |
| Chen, X | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma[NCT02542514] | Phase 2 | 52 participants (Actual) | Interventional | 2015-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for adenine and Cancer of the Retina
| Article | Year |
|---|---|
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) net
Topics: Adenine; Aged; Aged, 80 and over; Central Nervous System Neoplasms; Drug Resistance, Neoplasm; Femal | 2019 |
2 other studies available for adenine and Cancer of the Retina
| Article | Year |
|---|---|
Rapid Resolution of Presumed Vitreoretinal Lymphoma With Systemic Ibrutinib Therapy.
Topics: Adenine; Eye Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Piperidines; Retinal Neoplasms; Vit | 2021 |
Low concentrations of chloroquine and 3-methyladenine suppress the viability of retinoblastoma cells synergistically with vincristine independent of autophagy inhibition.
Topics: Adenine; Antineoplastic Agents, Phytogenic; Antirheumatic Agents; Apoptosis; Autophagy; Blotting, We | 2015 |